Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition

Journal of Vascular Access

Volumn 14, Issue 4, 2013, Pages 379-382

  Al Amin, Azzam H ^a   Sarveswaran, Janahan ^a   Wood, Jonathan M ^a   Burke, Dermot A ^a   Donnellan, Clare F ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Bloodstream; Catheter; Infection; Nutrition; Parenteral; Taurolidine

Indexed keywords

TAUROLIDINE; TAUROLOCK; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CATHETER INFECTION; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; MALE; MORBIDITY; PARENTERAL NUTRITION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARENTERAL NUTRITION, HOME; RECURRENCE; RETROSPECTIVE STUDIES; TAURINE; THIADIAZINES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84889679242     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/jva.5000168     Document Type: Article

References (16)

1. Santarpia L, Alfonsi L, Tiseo D, Creti R, Baldassarri L, Pasanisi F. Central venous catheter infections and antibiotic therapy during long-term home parenteral nutrition: an 11-year follow-up study. JPEN J Parenter Enteral Nutr. 2010;34(3): 254-262.
2. Clare A, Teubner A, Shaffer JL. What information should lead to a suspicion of catheter sepsis in HPN? Clin Nutr. 2008;27(4):552-556.
3. Shah CB, Mittelman MW, Costerton JW, et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother. 2002;46(6):1674-1679.
4. Opilla MT, Kirby DF, Edmond MB. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 2007;31(4):302-305.
5. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284(5418):1318-1322.
6. Torres-Viera C, Thauvin-Eliopoulos C, Souli M, et al. Activities of taurolidine in vitro and in experimental enterococcal endocarditis. Antimicrob Agents Chemother. 2000;44(6): 1720-1724.
7. Branger B, Marion K, Bergeron E, et al. Using detachmentpromoting agents for the prevention of chronic peritoneal dialysis-associated infections. Artif Organs. 2008; 32(12):918-924.
8. Ledson MJ, Gallagher MJ, Robinson M, et al. A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia. J Aerosol Med. 2002;15(1):51-57.
9. Catton JA, Dobbins BM, Kite P, et al. In situ diagnosis of intravascular catheter-related bloodstream infection: a comparison of quantitative culture, differential time to positivity, and endoluminal brushing. Crit Care Med. 2005;33(4): 787-791.
10. Betjes MGH, van Agteren M. Prevention of dialysis catheterrelated sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant. 2004;19(6):1546-1551.
11. Bisseling TM, Willems MC, Versleijen MW, Hendriks JC, Vissers RK, Wanten GJ. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin Nutr. 2010;29(4):464-468.
12. Handrup MM, Fuursted K, Funch P, Møller JK, Schrøder H. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin. APMIS. 2012;120(10): 794-801.
13. Jurewitsch B, Lee T, Park J, Jeejeebhoy K. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. JPEN J Parenter Enteral Nutr. 1998;22(4):242-244.
14. Jurewitsch B, Jeejeebhoy KN. Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections. Clin Nutr. 2005;24(3):462-465.
15. Touré A, Lauverjat M, Peraldi C, et al. Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patients. Clin Nutr. 2012;31(4):567-570.
16. Bradshaw JH, Puntis JW. Taurolidine and catheter-related bloodstream infection: a systematic review of the literature. J Pediatr Gastroenterol Nutr. 2008;47(2):179-186.